Nurse-led Multidisciplinary Precision Care for Patients With Chronic Heart Failure

Chronic Heart Failure Clinical Trial

Official title:

Nurse-led Multidisciplinary Precision Care for Patients With Chronic Heart Failure

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05987267
• Other study ID #: K2019-017
• Status: Active, not recruiting
• Phase: N/A
• Start date: November 24, 2021
• Est. completion date: December 31, 2024

Study information

• Verified date: August 2023
• Source: Zhongshan People's Hospital, Guangdong, China
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aimed to evaluate the feasibility and effectiveness of a nurse-led multidisciplinary precision care in early cardiac rehabilitation of patients with chronic heart failure, and further to promote the application of nurse-led multidisciplinary precision care.

Description:

Enrolled patients were randomly divided as 1:1 ratio to experimental group and control group, while experimental group received nurse-led multidisciplinary precision care and the control group received standard care according to guidelines. The primary and secondary outcomes were evaluated and analyzed.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 96
• Est. completion date: December 31, 2024
• Est. primary completion date: April 10, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Aged from 18 to 80 years;

• Conscious, with normal cognitive function and being communicable;

• NYHA heart function class II-IV;

• Patients met the diagnostic criteria of the clinical guidelines for the diagnosis and treatment of heart failure and were diagnosed with chronic heart failure;

• Informed consent was obtained.

Exclusion Criteria:

• Patients with congenital heart disease, cardiac shock, or persistent hypotension;

• Patients with severe liver and kidney dysfunction, moderate to severe anemia or coagulation disorders, and other serious systemic complications;

• Patients with a history of mental illness, a state of severe anxiety or depression, cognitive or communication impairments, and inability to communicate and respond to investigations;

• Patients have been involved in other research that would interfere with this study;

• Patients who declined cardiac rehabilitation and signed informed consent.

Related Conditions & MeSH terms

• Chronic Heart Failure
• Heart Failure
• Multidisciplinary Communication
• Nurse's Role

Intervention

Other:
• multidisciplinary precision care
The experimental group received precision nursing based on a multidisciplinary collaborative team in addition to standard treatment and care

Locations

Country	Name	City	State
China	Zhongshan City People's Hospital	Zhongshan	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
Zhongshan People's Hospital, Guangdong, China

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	left ventricular ejection fraction		baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Primary	6-minute walking distance		baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Secondary	the European Organization for Research and Treatment of Cancer (EORTC) quality-of-life (QoL) questionnaires (QLQ) QLQ-C30 (version 3.0) score Quality of Life		baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Secondary	Symptom Check List-90		baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Secondary	Performance Status Score		baseline, pre-intervention, 1 month after intervention, 3 months after intervention
Secondary	Numbers of patients with cardiovascular complications		baseline, pre-intervention, 1 month after intervention, 3 months after intervention